written by reader The Alzheimer’s Association estimates that, “caring for individuals with Alzheimer’s will cost American society $20 trillion.”

By Britt, May 15, 2021

“One small biotech holds the key to a revolution in treating this dreaded disease.
Jeff Bezos, Goldman Sachs & a Big Pharma giant have invested billions into this unknown biotech.”
I own LLY and BIIB because hey have, it seems, drugs that may have some effect on dementia.
The newsletter is only $19.00, but I just want to find better informed types who are looking in the drug/biotech space who might have ideas about this “touted” company and any others that have a chance to slow down Alzheimers and dementia. I’m dealing with it in my family and I expect that it touches almost all of our lives.



This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.